Updates
UN Drug Report Shines Light on Cannabis, Cocaine and Methamphetamine Trends
The World Drug Report 2022 also details the environmental consequences of the illicit drugs trade, the expansion of synthetic drugs to new markets, and an all-time high in cocaine production. “Numbers for the manufacturing and seizures of many illicit drugs are...
Evaluating Disparities in Prescribing of Naloxone after ED Treatment of Opioid Overdose
Patients who initially survive opioid-related overdose are at high risk for subsequent mortality. This retrospective cohort study evaluated disparities in naloxone prescribing for patients who presented after opioid overdose in a large health system. Of included...
Study of Mortality in Adult Children of Parents with Alcohol Use Disorder
More than sixty million people worldwide have alcohol use disorder (AUD). Millions of children grow up with at least one parent with harmful alcohol use but not all of them are affected the same way or have negative outcomes. However, adverse effects of having a...
Laws for Expanding Access to Medications for OUD: A Legal Analysis of 16 States & Washington D.C
Medications for opioid use disorder (MOUDs) are the gold standard for OUD treatment but are underused. The authors of this study sought to identify and categorize MOUD state policy innovations. The analysis identified and categorized state MOUD-related statutes and...
UNC Study: Fourth-Generation Vaping Devices Increase Risk to Immune Cells
Not all electronic cigarette devices are created equal. Some fourth-generation models – such as Juul devices – are associated with unique changes in markers of immune responses inside our airways, according to a new peer-reviewed paper from UNC School of Medicine...
Percentage of Overdose Deaths Involving Methadone Declined Between January 2019 and August 2021
The percentage of methadone-involved overdose deaths relative to all drug overdose deaths declined from January 2019 to August 2021, according to a new study. Access to methadone, a medication to treat opioid use disorder, was expanded at the start of the COVID-19...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.